Literature DB >> 16476061

Mice overexpressing p40 in lungs have reduced leucocyte influx and slightly impaired resistance during tuberculosis.

Jaklien C Leemans1, Catharina W Wieland, Sandrine Florquin, Tom van der Poll, Margriet J B M Vervoordeldonk.   

Abstract

Interleukin (IL)-12 (p70) is a heterodimeric cytokine composed of p40 and p35, that plays a major role in the protective immune response to Mycobacterium tuberculosis. To define the role of p40 in lungs during pulmonary M. tuberculosis infection we generated transgenic (Tg) mice overexpressing p40 under control of the surfactant protein C promoter. Tg mice expressed the transgene in their lungs, yet demonstrated elevated pulmonary p40 protein levels. After infection, Tg mice displayed higher pulmonary p40 and p70 levels than wild type mice. Interferon-gamma concentrations were similar in uninfected and infected Tg and wild type mice, arguing against agonistic effects of p40. Tg mice demonstrated reduced recruitment of macrophages, lymphocytes and neutrophils to the lungs early after infection. This was accompanied by reduced pulmonary tumour necrosis factor-alpha, macrophage inflammatory protein (MIP)-2 and MIP-1alpha levels. This suggests that elevated p40 concentrations inhibited the chemotactic effects of p70 on leucocytes. Furthermore, Tg mice displayed slightly higher pulmonary mycobacterial outgrowth late in the infection than wild type mice. Taken together, we demonstrate that constitutive overexpression of p40 in lungs negatively influences IL-12-mediated leucocyte migration and protection against lung tuberculosis. This suggests a novel antagonistic role for p40 homodimers in regulating the chemotactic bioactivity of IL-12 after pulmonary mycobacterial infection.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16476061      PMCID: PMC1782238          DOI: 10.1111/j.1365-2567.2005.02315.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  36 in total

1.  Pulmonary interleukin-23 gene delivery increases local T-cell immunity and controls growth of Mycobacterium tuberculosis in the lungs.

Authors:  Kyle I Happel; Euan A Lockhart; Carol M Mason; Elizabeth Porretta; Elizabeth Keoshkerian; Anthony R Odden; Steve Nelson; Alistair J Ramsay
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

2.  Chemokine networks in vivo: involvement of C-X-C and C-C chemokines in neutrophil extravasation in vivo in response to TNF-alpha.

Authors:  P A Tessier; P H Naccache; I Clark-Lewis; R P Gladue; K S Neote; S R McColl
Journal:  J Immunol       Date:  1997-10-01       Impact factor: 5.422

Review 3.  The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses.

Authors:  M K Gately; L M Renzetti; J Magram; A S Stern; L Adorini; U Gubler; D H Presky
Journal:  Annu Rev Immunol       Date:  1998       Impact factor: 28.527

4.  Alloantigen-reactive Th1 development in IL-12-deficient mice.

Authors:  J R Piccotti; K Li; S Y Chan; J Ferrante; J Magram; E J Eichwald; D K Bishop
Journal:  J Immunol       Date:  1998-02-01       Impact factor: 5.422

5.  Depletion of alveolar macrophages exerts protective effects in pulmonary tuberculosis in mice.

Authors:  J C Leemans; N P Juffermans; S Florquin; N van Rooijen; M J Vervoordeldonk; A Verbon; S J van Deventer; T van der Poll
Journal:  J Immunol       Date:  2001-04-01       Impact factor: 5.422

6.  Human SP-C gene sequences that confer lung epithelium-specific expression in transgenic mice.

Authors:  S W Glasser; M S Burhans; S K Eszterhas; M D Bruno; T R Korfhagen
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2000-05       Impact factor: 5.464

Review 7.  Type 1/Type 2 immunity in infectious diseases.

Authors:  B Spellberg; J E Edwards
Journal:  Clin Infect Dis       Date:  2000-12-15       Impact factor: 9.079

8.  Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12.

Authors:  B Oppmann; R Lesley; B Blom; J C Timans; Y Xu; B Hunte; F Vega; N Yu; J Wang; K Singh; F Zonin; E Vaisberg; T Churakova; M Liu; D Gorman; J Wagner; S Zurawski; Y Liu; J S Abrams; K W Moore; D Rennick; R de Waal-Malefyt; C Hannum; J F Bazan; R A Kastelein
Journal:  Immunity       Date:  2000-11       Impact factor: 31.745

9.  IL-12 exacerbates helminth-mediated corneal pathology by augmenting inflammatory cell recruitment and chemokine expression.

Authors:  E Pearlman; J H Lass; D S Bardenstein; E Diaconu; F E Hazlett; J Albright; A W Higgins; J W Kazura
Journal:  J Immunol       Date:  1997-01-15       Impact factor: 5.422

10.  Transtracheal administration of interleukin-12 induces neutrophil responses in the murine lung.

Authors:  Z Papp; D M Middleton; C M Røntved; M Foldvari; J R Gordon; M E Baca-Estrada
Journal:  J Interferon Cytokine Res       Date:  2000-02       Impact factor: 2.607

View more
  4 in total

1.  IL12B expression is sustained by a heterogenous population of myeloid lineages during tuberculosis.

Authors:  Allison E Reeme; Halli E Miller; Richard T Robinson
Journal:  Tuberculosis (Edinb)       Date:  2013-03-13       Impact factor: 3.131

2.  IL-12 p80-dependent macrophage recruitment primes the host for increased survival following a lethal respiratory viral infection.

Authors:  Sean Gunsten; Cassandra L Mikols; Mitchell H Grayson; Reto A Schwendener; Eugene Agapov; Rose M Tidwell; Carolyn L Cannon; Steven L Brody; Michael J Walter
Journal:  Immunology       Date:  2008-09-06       Impact factor: 7.397

3.  Interleukin-12p40 overexpression promotes interleukin-12p70 and interleukin-23 formation but does not affect bacille Calmette-Guérin and Mycobacterium tuberculosis clearance.

Authors:  Maria L Olleros; Dominique Vesin; Eduardo Martinez-Soria; Cindy Allenbach; Fabienne Tacchini-Cottier; Jean-Claude Pache; Gilles Marchal; Jubayer Rahman; Carmen Fernández; Shozo Izui; Irene Garcia
Journal:  Immunology       Date:  2007-07-09       Impact factor: 7.397

4.  Mycolic acid modification by the mmaA4 gene of M. tuberculosis modulates IL-12 production.

Authors:  Dee N Dao; Kari Sweeney; Tsungda Hsu; Sudagar S Gurcha; Ivan P Nascimento; Dan Roshevsky; Gurdyal S Besra; John Chan; Steven A Porcelli; William R Jacobs
Journal:  PLoS Pathog       Date:  2008-06-06       Impact factor: 6.823

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.